Annual CFO
-$436.85 M
+$65.43 M+13.03%
December 31, 2023
Summary
- As of February 12, 2025, BPMC annual cash flow from operations is -$436.85 million, with the most recent change of +$65.43 million (+13.03%) on December 31, 2023.
- During the last 3 years, BPMC annual CFO has fallen by -$823.88 million (-212.87%).
- BPMC annual CFO is now -212.87% below its all-time high of $387.04 million, reached on December 31, 2020.
Performance
BPMC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$13.64 M
+$34.44 M+71.63%
September 30, 2024
Summary
- As of February 12, 2025, BPMC quarterly cash flow from operations is -$13.64 million, with the most recent change of +$34.44 million (+71.63%) on September 30, 2024.
- Over the past year, BPMC quarterly CFO has increased by +$90.85 million (+86.95%).
- BPMC quarterly CFO is now -102.19% below its all-time high of $622.33 million, reached on September 30, 2020.
Performance
BPMC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$242.15 M
+$90.85 M+27.28%
September 30, 2024
Summary
- As of February 12, 2025, BPMC TTM cash flow from operations is -$242.15 million, with the most recent change of +$90.85 million (+27.28%) on September 30, 2024.
- Over the past year, BPMC TTM CFO has increased by +$237.17 million (+49.48%).
- BPMC TTM CFO is now -159.27% below its all-time high of $408.58 million, reached on June 30, 2021.
Performance
BPMC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BPMC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.0% | +87.0% | +49.5% |
| 3 y3 years | -212.9% | +89.5% | +52.0% |
| 5 y5 years | -149.6% | +89.5% | +52.0% |
BPMC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.3% | +13.0% | at high | +89.7% | at high | +52.0% |
| 5 y | 5-year | -212.9% | +13.0% | -102.2% | +89.7% | -159.3% | +52.0% |
| alltime | all time | -212.9% | +13.0% | -102.2% | +89.7% | -159.3% | +52.0% |
Blueprint Medicines Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.64 M(-71.6%) | -$242.15 M(-27.3%) |
| Jun 2024 | - | -$48.07 M(-52.6%) | -$333.00 M(-19.8%) |
| Mar 2024 | - | -$101.51 M(+28.6%) | -$415.40 M(-4.9%) |
| Dec 2023 | -$436.85 M(-13.0%) | -$78.93 M(-24.5%) | -$436.85 M(-8.9%) |
| Sep 2023 | - | -$104.48 M(-19.9%) | -$479.32 M(-5.0%) |
| Jun 2023 | - | -$130.47 M(+6.1%) | -$504.73 M(+2.5%) |
| Mar 2023 | - | -$122.96 M(+1.3%) | -$492.51 M(-1.9%) |
| Dec 2022 | -$502.28 M(+68.2%) | -$121.41 M(-6.5%) | -$502.28 M(+27.2%) |
| Sep 2022 | - | -$129.89 M(+9.8%) | -$394.99 M(+9.5%) |
| Jun 2022 | - | -$118.26 M(-10.9%) | -$360.69 M(+18.0%) |
| Mar 2022 | - | -$132.73 M(+840.4%) | -$305.60 M(+2.3%) |
| Dec 2021 | -$298.65 M(-177.2%) | -$14.11 M(-85.2%) | -$298.65 M(-3.5%) |
| Sep 2021 | - | -$95.60 M(+51.3%) | -$309.34 M(-175.7%) |
| Jun 2021 | - | -$63.16 M(-49.8%) | $408.58 M(+10.3%) |
| Mar 2021 | - | -$125.78 M(+407.2%) | $370.58 M(-4.3%) |
| Dec 2020 | $387.04 M(-239.2%) | -$24.80 M(-104.0%) | $387.04 M(+5.5%) |
| Sep 2020 | - | $622.33 M(-715.2%) | $366.94 M(-212.2%) |
| Jun 2020 | - | -$101.16 M(-7.5%) | -$327.09 M(+6.5%) |
| Mar 2020 | - | -$109.33 M(+143.5%) | -$307.15 M(+10.5%) |
| Dec 2019 | -$278.01 M | -$44.90 M(-37.4%) | -$278.01 M(-7.5%) |
| Sep 2019 | - | -$71.70 M(-11.7%) | -$300.70 M(+5.9%) |
| Jun 2019 | - | -$81.23 M(+1.3%) | -$284.00 M(+38.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$80.19 M(+18.7%) | -$205.63 M(+17.5%) |
| Dec 2018 | -$175.01 M(+46.0%) | -$67.58 M(+22.9%) | -$175.01 M(+23.1%) |
| Sep 2018 | - | -$55.01 M(+1823.9%) | -$142.18 M(+25.1%) |
| Jun 2018 | - | -$2.86 M(-94.2%) | -$113.69 M(-17.8%) |
| Mar 2018 | - | -$49.56 M(+42.6%) | -$138.35 M(+15.4%) |
| Dec 2017 | -$119.86 M(+389.0%) | -$34.75 M(+31.0%) | -$119.86 M(+15.4%) |
| Sep 2017 | - | -$26.52 M(-3.6%) | -$103.91 M(+8.2%) |
| Jun 2017 | - | -$27.52 M(-11.5%) | -$96.03 M(+11.2%) |
| Mar 2017 | - | -$31.08 M(+65.3%) | -$86.34 M(+252.2%) |
| Dec 2016 | -$24.51 M(-22.6%) | -$18.80 M(+0.9%) | -$24.51 M(+30.7%) |
| Sep 2016 | - | -$18.63 M(+4.5%) | -$18.76 M(+49.0%) |
| Jun 2016 | - | -$17.83 M(-158.0%) | -$12.59 M(+116.6%) |
| Mar 2016 | - | $30.75 M(-335.7%) | -$5.82 M(-81.6%) |
| Dec 2015 | -$31.68 M(-10.5%) | -$13.05 M(+4.7%) | -$31.68 M(+4.9%) |
| Sep 2015 | - | -$12.46 M(+12.8%) | -$30.21 M(+14.8%) |
| Jun 2015 | - | -$11.05 M(-326.1%) | -$26.31 M(+10.1%) |
| Mar 2015 | - | $4.89 M(-142.2%) | -$23.90 M(-32.5%) |
| Dec 2014 | -$35.40 M(+86.1%) | -$11.58 M(+35.2%) | -$35.40 M(+48.6%) |
| Sep 2014 | - | -$8.57 M(-0.9%) | -$23.82 M(+56.2%) |
| Jun 2014 | - | -$8.64 M(+30.8%) | -$15.25 M(+130.8%) |
| Mar 2014 | - | -$6.61 M | -$6.61 M |
| Dec 2013 | -$19.02 M | - | - |
FAQ
- What is Blueprint Medicines annual cash flow from operations?
- What is the all time high annual CFO for Blueprint Medicines?
- What is Blueprint Medicines annual CFO year-on-year change?
- What is Blueprint Medicines quarterly cash flow from operations?
- What is the all time high quarterly CFO for Blueprint Medicines?
- What is Blueprint Medicines quarterly CFO year-on-year change?
- What is Blueprint Medicines TTM cash flow from operations?
- What is the all time high TTM CFO for Blueprint Medicines?
- What is Blueprint Medicines TTM CFO year-on-year change?
What is Blueprint Medicines annual cash flow from operations?
The current annual CFO of BPMC is -$436.85 M
What is the all time high annual CFO for Blueprint Medicines?
Blueprint Medicines all-time high annual cash flow from operations is $387.04 M
What is Blueprint Medicines annual CFO year-on-year change?
Over the past year, BPMC annual cash flow from operations has changed by +$65.43 M (+13.03%)
What is Blueprint Medicines quarterly cash flow from operations?
The current quarterly CFO of BPMC is -$13.64 M
What is the all time high quarterly CFO for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash flow from operations is $622.33 M
What is Blueprint Medicines quarterly CFO year-on-year change?
Over the past year, BPMC quarterly cash flow from operations has changed by +$90.85 M (+86.95%)
What is Blueprint Medicines TTM cash flow from operations?
The current TTM CFO of BPMC is -$242.15 M
What is the all time high TTM CFO for Blueprint Medicines?
Blueprint Medicines all-time high TTM cash flow from operations is $408.58 M
What is Blueprint Medicines TTM CFO year-on-year change?
Over the past year, BPMC TTM cash flow from operations has changed by +$237.17 M (+49.48%)